[HTML][HTML] Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies

IA Abela, L Berlinger, M Schanz, L Reynell… - PLoS …, 2012 - journals.plos.org
HIV is known to spread efficiently both in a cell-free state and from cell to cell, however the
relative importance of the cell-cell transmission mode in natural infection has not yet been …

[HTML][HTML] Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?

H Subbaraman, M Schanz, A Trkola - Retrovirology, 2018 - Springer
The elicitation of broadly neutralizing antibodies (bnAbs) is considered crucial for an effective,
preventive HIV-1 vaccine. Led by the discovery of a new generation of potent bnAbs, the …

[HTML][HTML] Determinants of HIV-1 broadly neutralizing antibody induction

P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz… - Nature medicine, 2016 - nature.com
Broadly neutralizing antibodies (bnAbs) are a focal component of HIV-1 vaccine design, yet
basic aspects of their induction remain poorly understood. Here we report on viral, host and …

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools

…, IA Abela, SR Haile, C Berger, M Huber, M Schanz… - bmj, 2021 - bmj.com
Objectives To examine longitudinal changes in severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) seroprevalence and to determine the clustering of children who were …

[HTML][HTML] Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity

…, S Epp, ME Sickmann, MM Schanz… - Nature …, 2021 - nature.com
Determination of SARS-CoV-2 antibody responses in the context of pre-existing immunity to
circulating human coronavirus (HCoV) is critical for understanding protective immunity. Here …

[HTML][HTML] Capacity of broadly neutralizing antibodies to inhibit HIV-1 cell-cell transmission is strain-and epitope-dependent

L Reh, C Magnus, M Schanz, J Weber, T Uhr… - PLoS …, 2015 - journals.plos.org
An increasing number of broadly neutralizing antibodies (bnAbs) are considered leads for
HIV-1 vaccine development and novel therapeutics. Here, we systematically explored the …

[HTML][HTML] Tracing HIV-1 strains that imprint broadly neutralizing antibody responses

…, C Kadelka, M Huber, A Marzel, H Ebner, M Schanz… - Nature, 2018 - nature.com
Understanding the determinants of broadly neutralizing antibody (bNAb) evolution is crucial
for the development of bNAb-based HIV vaccines 1 . Despite emerging information on …

Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in …

…, C Capelli, C Berger, A Frei, M Huber, M Schanz… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To determine the variation in SARS-CoV-2 seroprevalence in school children
and the relationship with self-reported symptoms. Design Baseline measurements of a …

[HTML][HTML] Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity

C Kadelka, T Liechti, H Ebner, M Schanz… - Journal of experimental …, 2018 - rupress.org
Understanding pathways that promote HIV-1 broadly neutralizing antibody (bnAb) induction
is crucial to advance bnAb-based vaccines. We recently demarcated host, viral, and disease …

[HTML][HTML] High-throughput sequencing of human immunoglobulin variable regions with subtype identification

M Schanz, T Liechti, O Zagordi, E Miho, ST Reddy… - PloS one, 2014 - journals.plos.org
The humoral immune response plays a critical role in controlling infection, and the rapid
adaptation to a broad range of pathogens depends on a highly diverse antibody repertoire. The …